Global distribution and epidemiologic associations of escherichia coli clonal group A, 1998-2007

Emerging Infectious Diseases

Volumn 17, Issue 11, 2011, Pages 2001-2009

  Johnson, James R ^a,b   Menard, Megan E ^a   Lauderdale, Tsai Ling ^c   Kosmidis, Chris ^d   Gordon, David ^e   Collignon, Peter ^e,f   Maslow, Joel N ^a,g   Andrǎević, Arjana Tambić ^h   Kuskowski, Michael A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^f CANBERRA HOSPITAL   (Australia)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Croatia   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; AUSTRALIA AND NEW ZEALAND; BACTERIUM ISOLATE; CENTRAL AMERICA; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI CLONAL GROUP A; EUROPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL PATIENT; HUMAN; MOLECULAR PHYLOGENY; NONHUMAN; NORTH AMERICA; OUTPATIENT; PREVALENCE; PUBLIC HEALTH PROBLEM; SOUTH AMERICA; TREND STUDY; UNITED STATES; URINE;

EID: 84930484579     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1711.110488     Document Type: Article

References (25)

1. Russo TA, Johnson JR. Medical and economic impact of extraintes-tinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect. 2003;5:449-56. doi:10.1016/S1286-4579(03)00049-2
2. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007-13. doi:10.1056/NEJMoa011265
3. Manges AR, Naterajan P, Solberg OD, Dietrich PS, Riley LW. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol Infect. 2006;134:425-31. doi:10.1017/ S0950268805005005
4. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Esch-erichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimi-crob Chemother. 2008;61:273-81. doi:10.1093/jac/dkm464
5. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002- 2004. Antimicrob Agents Chemother. 2009;53:2733-9. doi:10.1128/ AAC.00297-09
6. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin Infect Dis. 2010;51:286-94. doi:10.1086/653932
7. Russo TA, Johnson JR. A proposal for an inclusive designation for extraintestinal pathogenic Escherichia coli: ExPEC. J Infect Dis. 2000;181:1753-4. doi:10.1086/315418
8. Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43:5860-4. doi:10.1128/ JCM.43.12.5860-5864.2005
9. Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. Phylogenetic relationships among clonal groups of extraintesti-nal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 2006;8:1702-13. doi:10.1016/j. micinf.2006.02.007
10. Johnson JR, Manges AR, O'Bryan TT, Riley LR. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet. 2002;359:2249-51. doi:10.1016/S0140-6736(02)09264-4
11. Lescat M, Calteau A, Hoede C, Barbe V, Touchon M, Rocha E, et al. A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A. Antimicrob Agents Chemother. 2009;53:2283-8. doi:10.1128/AAC.00123-09
12. Burman WJ, Breese PE, Murray BE, Singh KV, Batal HA, MacKenzie TD, et al. Conventional and molecular epidemiology of trimethoprim/sulfamethoxazole resistance among urinary Esch-erichia coli isolates. Am J Med. 2003;115:358-64. doi:10.1016/ S0002-9343(03)00372-3
13. Smith SP, Manges AR, Riley LW. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis. 2008;46:689-95. doi:10.1086/527386
14. Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prère MF, Picard B, et al. Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis. 2005;11:141-5.
15. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Mi-crobiol. 2000;66:4555-8. doi:10.1128/AEM.66.10.4555-4558.2000
16. Johnson JR, Owens, Manges A, Riley L. Rapid and specific detection of Escherichia coli clonal group A by gene-specifi c PCR. J Clin Mi-crobiol. 2004;42:2618-22. doi:10.1128/JCM.42.6.2618-2622.2004
17. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swami-nathan B, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:59-67. doi:10.1089/fpd.2006.3.59
18. Boczek LA, Rice EW, Johnston B, Johnson JR. Occurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluents. Appl Environ Microbiol. 2007;73:4180-4. doi:10.1128/AEM.02225-06
19. Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim/sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother. 2008;52:846-51. doi:10.1128/AAC.01200-07
20. Manges AR, Dietrich PS, Riley LW. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis. 2004;38:329-34. doi:10.1086/380640
21. Johnson JR, Russo TA. Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis. 2002;186:859-64. doi:10.1086/342490
22. Johnson JR, Delavari P, O'Bryan T. Escherichia coli O18:K1:H7 isolates from acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profi les. J Infect Dis. 2001;183:425-34. doi:10.1086/318086
23. Kunin CM, Hua TH, Krishman C, van Arsdale White L, Hacker J. Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis. Clin Infect Dis. 1993;16:412-6. doi:10.1093/clind/16.3.412
24. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofl oxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol. 2008;46:2605-12. doi:10.1128/JCM.00640-08
25. Johnson JR, Stell AL, O'Bryan TT, Kuskowski M, Nowicki B, Johnson C, et al. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol. 2002;40:1913-23. doi:10.1128/JCM.40.6.1913-1923.2002